文献速递乳腺外科围术期管理与 ERAS

2型糖尿病对原发性乳腺癌手术后并发症的影响:丹麦人群队列研究

Impact of type 2 diabetes on complications after primary breast cancer surgery: Danish population-based cohort study.
PubMed 文献 · Br J Surg · 2024-01-01

基于丹麦乳腺癌协作组临床数据库1996—2022年98 589例早期乳腺癌女性队列,2型糖尿病患者6 332例(6.4%)。有2型糖尿病者30天并发症累积发生率为16%(95%CI 15%~17%),无2型糖尿病者为11%(95%CI 10%~11%),HR为1.43(95%CI 1.34~1.53)。2型糖尿病与中度及重度合并症的交互作用分别解释了21%和42%的手术并发症发生率。

要点

  • 有2型糖尿病者术后30天并发症累积发生率为16%,无2型糖尿病者为11%。
  • 2型糖尿病与术后并发症风险升高相关,HR为1.43(95%CI 1.34~1.53)。
  • 2型糖尿病与中度、重度合并症的交互作用分别解释了21%和42%的并发症发生率。

核心结论

  • 有2型糖尿病的乳腺癌女性原发性乳腺癌手术后并发症风险高于无2型糖尿病者。
  • 2型糖尿病与合并症对手术并发症存在协同效应,可解释这一关联。

研究设计与样本

  • 基于丹麦乳腺癌协作组临床数据库建立1996—2022年丹麦所有早期乳腺癌女性队列,均接受乳房切除或保乳手术。
  • 从丹麦医疗与处方登记库收集2型糖尿病信息;手术并发症定义为原发性乳腺癌手术后30天内出现的医疗或手术并发症住院诊断。
  • 计算30天并发症累积发生比例,采用Cox回归估计HR,并计算交互对比以确定2型糖尿病与合并症对并发症发生率的相加交互作用。

主要发现

  • 98 589例乳腺癌女性中,6 332例(6.4%)在乳腺癌手术时患有2型糖尿病。
  • 有2型糖尿病者1 038例(16.4%)、无2型糖尿病者9 861例(10.7%)发生手术并发症。
  • 有2型糖尿病者30天并发症累积发生比例为16%(95%CI 15%~17%),无2型糖尿病者为11%(95%CI 10%~11%)。
  • 有2型糖尿病者手术并发症HR为1.43(95%CI 1.34~1.53)。
  • 2型糖尿病与中度合并症交互作用解释的手术并发症发生率为21%,与重度合并症交互作用解释的为42%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Knowledge is sparse on the impact of type 2 diabetes (T2D) on surgical outcomes after breast cancer surgery. This study investigated the association between T2D and risk of complications after primary breast cancer surgery, and evaluated the biological interaction between T2D and co-morbidities. METHODS: Using the Danish Breast Cancer Group clinical database, a cohort of all Danish women diagnosed with early-stage breast cancer during 1996-2022 was created. All patients underwent mastectomy or breast-conserving surgery. Information on prevalent T2D was collected from Danish medical and prescription registries. Surgical complications were defined as hospital diagnoses for medical or surgical complications developing within 30 days after primary breast cancer surgery. The 30-day cumulative incidence proportion of complications was calculated, and Cox regression was used to estimate HRs. Interaction contrasts were computed to determine the additive interaction between T2D and co-morbidities on the incidence rate of complications. RESULTS: Among 98 589 women with breast cancer, 6332 (6.4%) had T2D at breast cancer surgery. Overall, 1038 (16.4%) and 9861 (10.7%) women with and without T2D developed surgical complications, yielding cumulative incidence proportions of 16 (95% c.i. 15 to 17) and 11 (10 to 11)% respectively, and a HR of 1.43 (95% c.i. 1.34 to 1.53). The incidence rate of surgical complications explained by the interaction of T2D with moderate and severe co-morbidity was 21 and 42%, respectively. CONCLUSION: Women with breast cancer and T2D had a higher risk of complications after primary breast cancer surgery than those without T2D. A synergistic effect of T2D and co-morbidity on surgical complications can explain this association.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Kjærgaard K, Wheler J, Dihge L, et al. Impact of type 2 diabetes on complications after primary breast cancer surgery: Danish population-based cohort study. Br J Surg. 2024. PMID: 38536933. doi:10.1093/bjs/znae072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。